Health Condition 1: null- Hypothyroidism
Conditions
Interventions
None listed
Sponsors
Abbott India Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of either gender, aged more than or equal to 18 years and less than or equal to 60 years diagnosed with primary hypothyroidism. 2. Currently on treatment with any brand of levothyroxin for at least 3 months and on a stable dose of thyroxin for at least 2 months prior to enrolment. 3. Willing to provide written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients receiving tri-iodothyronine (T3) as monotherapy or in combination with levothyroxin 2. Patients who are mentally retarded or unable to communicate 3. Patients with central hypothyroidism 4. Patients where hypothyroidism is likely to be transient 5. Pregnant and lactating women 6. Participating in any other clinical study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To assess percentage (%) of primary hypothyroid patients with abnormal thyroid function (measured using serum TSH level as surrogate marker of thyroid function) despite being prescribed levothyroxin for at least 2 months prior to enrolment in clinical practice among physicians across IndiaTimepoint: NA | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To assess reasons for out-of range serum TSH values which could be: a. Presence of confounding factors (age, etiology of hypothyroidism, concomitant medication and illness etc.) and failure to adjust thyroxin dose for such confounders b. Poor compliance on part of patients Timepoint: NA;2. To assess their quality of life Timepoint: NA | — |
Countries
India
Contacts
Public ContactDr Sakharam Garale
Abbott India Limited
Outcome results
None listed